Aims/hypothesis. We aimed to study the effects of two K ATP channel openers (KCO), diazoxide and the more potent compound NNC 55-0118, on beta-cell suppression and/or toxicity induced by alloxan, sodium nitroprusside and IL-1β. Methods. Islets from rats were exposed to 0.3 mmol/l diazoxide or NNC 55-0118 for 30 min and either alloxan (0.5 mmol/l), sodium nitroprusside (0.5 mmol/l) or IL-1β (12.5 or 25 U/ml) were added and the incubation continued for 30 min. Islets were then washed and incubated for 24 h before examination. Results. After exposure to alloxan, islets showed reduced glucose oxidation rate and impaired glucosestimulated insulin release. NNC 55-0118 counteracted the effects of alloxan, while diazoxide was less effective. After treatment with sodium nitroprusside, islet glucose oxidation rates were reduced and this was prevented by pretreatment with NNC 55-0118. In shortterm experiments the potassium channel openers (KCOs) did not influence the IL-1β effect on insulin secretion. However, long-term addition (24 h) of NNC 55-0118 counteracted IL-1β induced inhibition of the glucose oxidation rate. It was shown, using the fluorescent probe JC-1, that the mitochondrial membrane potential was reduced by the potassium channel openers (KCOs), most strongly by NNC 55-0118. Nevertheless culture with KCOs for 72 h did not cause irreversible damage to the islets. Conclusion/interpretation. Potassium channel openers (KCOs), in particular NNC 55-0118, prevented the toxic effects of alloxan and sodium nitroprusside. IL-1β mediated suppression was reduced by NNC 55-0118 provided the long-term addition of the potassium channel opener (KCO). The protective mechanism of potassium channel openers (KCOs) might involve a decrease of the mitochondrial membrane potential. [Diabetologia (2003) 46:80-88] Keywords Alloxan, interleukin-1β, mitochondria, nitric oxide, pancreatic islets, potassium channel opener, sodium nitroprusside. Environmental as well as immunological events are thought to be of importance for the destruction of the insulin-producing beta-cells in the islets of Langerhans in Type 1 diabetes [1]. The mechanisms and mediators of this process are not fully understood. There is evidence suggesting that a period of reduced activity following the start of insulin treatment is beneficial in new onset diabetes [2,3] and that the cellular activity affects the susceptibility to damage in vitro [4,5,6]. Inhibition of insulin secretion by the use of potassium channel openers (KCOs) provides a means of inducing 'beta-cell rest'. The drugs open the ATP-sensitive potassium channel (K ATP channel) and hyperpol-